These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8434433)

  • 21. Modern management for testicular teratoma.
    Read G
    Br J Hosp Med; 1996 Sep 4-17; 56(5):218-21. PubMed ID: 8879701
    [No Abstract]   [Full Text] [Related]  

  • 22. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testicular tumours in prepubertal children: About eight cases.
    Khemakhem R; Ahmed YB; Jlidi S; Nouira F; Fdhila F; Charieg A; Ghorbel S; Barsaoui S; Chaouachi B
    Afr J Paediatr Surg; 2013; 10(2):176-9. PubMed ID: 23860072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA; Bihrle R; Foster RS
    Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testicular tumors in children and adolescents.
    Taskinen S; Fagerholm R; Aronniemi J; Rintala R; Taskinen M
    J Pediatr Urol; 2008 Apr; 4(2):134-7. PubMed ID: 18631909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
    Korfel A; Fischer L; Foss HD; Koch HC; Thiel E
    Bone Marrow Transplant; 2001 Oct; 28(8):787-9. PubMed ID: 11781632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment and prognosis of testicular seminoma].
    Tsukamoto T; Fukui I
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):516-21. PubMed ID: 10790992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal malignancies several years after initial treatment of germ cell cancer of the testis.
    Maatman T; Bukowski RM; Montie JE
    Cancer; 1984 Nov; 54(9):1962-5. PubMed ID: 6541092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    J Urol; 2009 Jun; 181(6):2526-32. PubMed ID: 19371895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testicular germ cell tumors in children: management and outcome in a series of 20 patients.
    De Backer A; Madern GC; Wolffenbuttel KP; Oosterhuis JW; Hakvoort-Cammel FG; Hazebroek FW
    J Pediatr Urol; 2006 Jun; 2(3):197-201. PubMed ID: 18947609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular and paratesticular neoplasms in prepubertal males.
    Agarwal PK; Palmer JS
    J Urol; 2006 Sep; 176(3):875-81. PubMed ID: 16890643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
    Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of advanced germ-cell tumors of the testis.
    Fléchon A; Rivoire M; Droz JP
    Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
    Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
    Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growing teratoma syndrome.
    Karam JA; Raj GV
    Urology; 2009 Oct; 74(4):783-4. PubMed ID: 19647298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.